Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model (Q44685331)

5 December 2017

title

Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model (English)

1 reference

5 December 2017

Bok RA

1

1 reference

5 December 2017

Hansell EJ

2

1 reference

5 December 2017

Nguyen TP

3

1 reference

5 December 2017

Greenberg NM

4

1 reference

5 December 2017

McKerrow JH

5

1 reference

5 December 2017

Shuman MA

6

1 reference

5 December 2017

publication date

1 January 2003

1 reference

Prostate Cancer and Prostatic Diseases

5 December 2017

published in

1 reference

5 December 2017

volume

6

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

272-280

1 reference

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Prevention of metastasis by inhibition of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Proteolysis and cell migration: creating a path?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

Correlation of the osteoblastic phenotype with prostate-specific antigen expression in metastatic prostate cancer: implications for paracrine growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

7 January 2021

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

7 January 2021

Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

7 January 2021

Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500676

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500676

1 reference

5 December 2017

1 reference